Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.5B | 5.1B | 5.3B | 5.3B |
Cost of revenue | 1.3B | 1.5B | 1.5B | 1.6B |
Gross profit | 3.2B | 3.6B | 3.8B | 3.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 588M | 687M | 656M | 788M |
Other operating expenses | — | — | — | — |
Operating income | 2.7B | 2.9B | 3.2B | 2.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 262M | 342M | 267M | 261M |
Other income expense | -716M | 115M | 141M | 2.5B |
Pretax income | 1.7B | 2.8B | 3.0B | 5.1B |
Tax provision | 606M | -262M | 733M | 1.3B |
Net income | 1.1B | 3.0B | 2.3B | 3.8B |
Basic EPS | 0.6 | 1.8 | 1.3 | 2.2 |
Diluted EPS | 0.6 | 1.8 | 1.3 | 2.2 |
Basic average shares | 1.7B | 1.7B | 1.7B | 1.7B |
Diluted average shares | 1.7B | 1.7B | 1.7B | 1.7B |
EBITDA | 2.9B | 3.2B | 3.4B | 3.1B |
Net income from continuing op. | 1.1B | 3.0B | 2.3B | 3.8B |
Minority interests | — | — | — | — |
Preferred stock dividends | 5M | 8M | 6M | 9M |